Neurocognitive function among HIV-infected children on protease inhibitor -based versus non-protease inhibitor based antiretroviral therapy in Uganda: a pilot study

被引:1
|
作者
Nalwanga, Damalie [1 ,2 ]
Musiime, Victor [1 ,3 ]
Bangirana, Paul [4 ]
Nishiguchi, Erika Phelps [5 ]
Kiggwe, Andrew [2 ]
Ssesanga, Titus [3 ]
Ssenkusu, John M. [6 ]
Musoke, Philippa [1 ]
Cusick, Sarah E. [7 ]
机构
[1] Makerere Univ, Sch Med, Dept Paediat & Child Hlth, Coll Hlth Sci, POB 7072, Kampala, Uganda
[2] Makerere Univ Lung Inst, POB 7749, Kampala, Uganda
[3] Joint Clin Res Ctr, Res Dept, POB 10005, Kampala, Uganda
[4] Makerere Univ, Sch Med, Dept Psychiat, Coll Hlth Sci, POB 7072, Kampala, Uganda
[5] Univ Washington, Dept Paediat, Div Dev Behav Paediat, Seattle, WA 98195 USA
[6] Makerere Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Coll Hlth Sci, POB 7072, Kampala, Uganda
[7] Univ Minnesota, Dept Paediat, Minneapolis, MN USA
基金
美国国家卫生研究院;
关键词
Neurocognitive function; Children; HIV; ART; NEUROPSYCHOLOGICAL PERFORMANCE; COGNITIVE IMPAIRMENT; NAIVE; DEFICITS; OUTCOMES; CARE; ART;
D O I
10.1186/s12887-021-02676-2
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Background HIV infection is associated with significant neurocognitive deficits making maximization of cognitive function among children receiving antiretroviral therapy (ART) a public health imperative. Non-protease inhibitors (non-PIs) achieve higher drug levels in the cerebral spinal fluid (CSF) compared to PIs, potentially leading to better neurocognitive function by reducing CSF viral load and inflammation. ART that maximises children's neurodevelopment and school achievement could result in improved quality of life and productivity as adults, but little research to date has examined whether non-PI ART is associated with better neurocognitive outcomes. We compared the neurocognitive function between children living with HIV receiving PI-based and non PI-based ART. Methods We recruited a consecutive sample of clinically stable Ugandan children living with HIV aged 5-12 years who received PI-based or non PI-based ART for >= 1 year (viral load < 1000 copies). Neurocognitive function was assessed using the Kaufman Assessment Battery for Children, the Test of Variables of Attention, and Bruininks-Oseretsky Test of Motor Proficiency. Age-adjusted neurocognitive z-scores for the two groups were compared using linear regression models in STATA version 13. The Hommel's method was used to adjust for multiple testing. Results We enrolled 76 children living with HIV; 34 on PI ART and 42 on non-PI ART. Mean (+/- SD) age was greater in the non-PI vs. PI group (9.5 +/- 1.9 vs. 8.5 +/- 2.0) years (p = 0.03). Children in the non-PI group had lower socioeconomic scores (5.7 +/- 3.3 vs. 7.4 +/- 2.8, p = 0.02). There was no difference in neurocognitive function between the groups (adjusted p > 0.05) for KABC and TOVA. Children in the PI group had better total BOT scores than their counterparts (46.07 +/- 1.40) vs. 40.51 (1.24), p = 0.03). Conclusions We detected no difference in neurocognitive function among children on PI and non PI-based ART therapy based on KABC and TOVA tests. Children on PI based ART had better motor function than their counterparts. We recommend a prospective study with a larger sample size.
引用
收藏
页数:8
相关论文
共 50 条
  • [31] Prescribing of contraindicated protease inhibitor and statin combinations among HIV-infected persons
    Hulgan, T
    Sterling, TR
    Daugherty, J
    Arbogast, PG
    Raffanti, S
    Ray, W
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2005, 38 (03) : 277 - 282
  • [32] PLASMA PROTEASE INHIBITOR CONCENTRATIONS AND FASTING LIPID PROFILES IN HIV-INFECTED CHILDREN
    Rakhmanina, N.
    Rongen, Avan
    van den Anker, J.
    Soldin, S.
    Williams, L.
    Neely, M.
    JOURNAL OF CLINICAL PHARMACOLOGY, 2010, 50 (09): : 1078 - 1078
  • [33] Quality of life and depression among HIV-infected patients receiving efavirenz- or protease inhibitor-based therapy in Senegal
    Poupard, M.
    Gueye, N. F. Ngom
    Thiam, D.
    Ndiaye, B.
    Girard, P. M.
    Delaporte, E.
    Sow, P. S.
    Landman, R.
    HIV MEDICINE, 2007, 8 (02) : 92 - 95
  • [34] High hepatitis C virus viral load in HIV/hepatitis C virus-co-infected patients: a different influence of protease inhibitor and non-protease inhibitor-based HAART?
    Bani-Sadr, Firouze
    Goderel, Isabelle
    Morand, Patrice
    Payan, Christopher
    Lunel, Francoise
    Pol, Stanislas
    Perronne, Christian
    Carrat, Fabrice
    Cacoub, Patrice
    AIDS, 2007, 21 (12) : 1645 - 1648
  • [35] Relapse of Kaposi's Sarcoma and HHV-8 viremia in an HIV-infected patient switching from protease inhibitor to integrase inhibitor-based antiretroviral therapy
    Simonetti, Francesco Roberto
    Ricaboni, Davide
    Cattaneo, Dario
    Micheli, Valeria
    Rusconi, Stefano
    Gervasoni, Cristina
    JOURNAL OF CLINICAL VIROLOGY, 2016, 74 : 75 - 77
  • [36] Determinants of sustained virological suppression in indigent, HIV-infected patients: Is single protease inhibitor-based antiretroviral therapy truly highly active?
    Visnegarwala, F
    Graviss, EA
    Sajja, P
    Lahart, CJ
    White, AC
    HIV CLINICAL TRIALS, 2004, 5 (03): : 117 - 124
  • [37] Limitations of a simplification antiretroviral strategy for HIV-infected patients with decreasing adherence to a protease inhibitor regimen
    Moya, J.
    Casado, J. L.
    Aranzabal, L.
    Moreno, A.
    Antela, A.
    Dronda, F.
    Perez-Elías, M. J.
    Marin, A.
    Moreno, S.
    HIV CLINICAL TRIALS, 2006, 7 (04): : 210 - 214
  • [38] Boosted protease inhibitor-including versus a protease inhibitor-sparing regimen in protease inhibitor-resistant HIV-infected patients: 24-week immunological outcome
    Gianotti, N
    Soria, A
    Galli, L
    Giudici, B
    Fusetti, G
    Lazzarin, A
    Boeri, E
    Castagna, A
    AIDS, 2004, 18 (05) : 821 - 823
  • [39] Relapse of Kaposi's sarcoma in HIV-infected patients switching from a protease inhibitor to a non-nucleoside reverse transcriptase inhibitor-based highly active antiretroviral therapy regimen
    Bani-Sadr, F
    Fournier, S
    Molina, LM
    AIDS, 2003, 17 (10) : 1580 - 1581
  • [40] Efficacy of Pravastatin in Non-Nucleoside Reverse Transcriptase Inhibitor (NNRTI) and Protease Inhibitor (PI)-based HAART in HIV-Infected Patients
    Eaton, Susan A.
    Rahman, Anita P.
    Nguyen, Sean T.
    Bain, Amy M.
    Payne, Kenna D.
    Busti, Anthony J.
    AMERICAN JOURNAL OF INFECTIOUS DISEASES, 2008, 4 (02) : 124 - 130